• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Latest

Small-Cap Expert: Go Green in 2021 — ASX Pot Stocks Are Roaring

Like 0

By Callum Newman, Tuesday, 08 December 2020

Do you remember what I told you last Tuesday? Well done if so.

Personally, I can barely recall what I had for breakfast this morning!

Here’s a refresher…

I said watch cannabis stocks — the other ‘green’ revolution happening now.

A week can be a long time in the market.

ASX ‘Pot’ stocks are suddenly roaring.

Check out the rise in Creso Pharma Ltd [ASX:CPH], for example.

It’s up 200% in a week!

Stay up to date with the latest investment trends and opportunities. Click here to learn more.

Creso Pharma goes…BOOM!


Port Phillip Publishing

Source: Optuma

[Click to open in a new window]

Now that’s a ride!

Unfortunately for me, I wasn’t on that one.

But subscribers to Ryan Dinse’s Small-Cap Momentum Alert were.

Ryan got them on the stock around 3.5 cents. Today, it’s around 16 cents…all in less than a month.

That’s the potential of the small-cap space, though it does come with added volatility risk.

I’m not saying to chase this stock.

A rally like that can usually only go so far.

However, I do think the opportunities in cannabis will keep coming.

The cannabis stocks moving powerfully now were the stocks heavily beaten up in the previous 12–18 months.

They are not necessarily the ones I am looking to hold for the long term.

What’s Behind the ASX Pot Stocks Rally?

But what caused this rally in the first place?

There’s been some nice news flow, lately, for the ‘big picture’.

Last week the UN said it was reclassifying cannabis away from being a Schedule IV drug (equivalent to heroin) to a Schedule I.

This opens up the possibility of further research and medicinal use.

Several of the cannabis names also released different news yesterday.

It was this…

The US House of Representatives just passed a bill called the ‘MORE’ Act.

It’s to decriminalise cannabis at the national level in the US.

It sounds a lot more exciting than it is.

This legislation has to pass through the Senate as well.

The odds of that happening aren’t great.

Certainly, decriminalisation at the US federal level — whenever it comes — would be massive for the cannabis industry.

But it’s powering along here in Australia even without it.

By the way, if you’re not familiar with this space, the US is operating a strange dynamic currently.

Individual states are legislating rules for cannabis while the federal government maintains it’s all illegal — but doesn’t do anything to stop it.

The goods news for Aussie firms is that the US isn’t the only one playing the field (though it is the biggest).

The other lucrative market is Europe, especially Germany. The UK isn’t too far away from being an important importer, either.

Why do you and I care?

It gives Aussie cannabis companies a global growth profile and lots of potential customers.

One man who has followed cannabis since the industry began in 2017 is Ryan Clarkson-Ledward over at Australian Small-Cap Investigator.

I checked in with him for his latest views on what’s happening.

He says…

‘There is also the possibility of more good news on the horizon.

‘The Therapeutic Goods Administration (TGA) has spent much of 2020 debating the future of CBD — one of the two key ingredients in cannabis that isn’t responsible for the psychoactive effects.

‘A substance that has shown great promise for its therapeutic benefits with few side effects.

‘That’s why back in April, the TGA began consulting about proposed changes to access for CBD.

‘Potentially even making it possible to get access to certain formulations without a prescription. Effectively making it an “over-the-counter” drug that anyone can purchase from a pharmacy.

‘Keep in mind, this is purely for CBD products — not cannabis as a whole.

‘These drugs can’t and won’t cause any psychoactive high. They’re purely for medicinal use.

‘A decision on this matter was set to be made on 25 November. But, in the report released on that date, the TGA confirmed the final ruling wouldn’t be made until “late December”.

‘So, we will have to wait a few more weeks for the ultimate decision.

‘But if it passes, it will be a huge outcome for some of our local pot stocks. Making it far easier to market and sell their medicinal products to consumers. With a favourable ruling set to be implemented by 1 June 2021.

‘For these reasons, the pot stock boom may be about to kick off once more.’

If you’re keen to follow Ryan and have a chance to profit from this potential new marijuana move, I suggest you jump on board with him before pot stocks really start moving.

Best wishes,

Callum Newman Signature

Callum Newman,
Editor, The Daily Reckoning Australia

PS: Our publication The Daily Reckoning is a fantastic place to start your investment journey. We talk about the big trends driving the most innovative stocks on the ASX. Learn all about it here.

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Callum Newman

Callum Newman is a real student of the markets. He’s been studying, writing about, and investing for more than 15 years. Between 2014 and 2016, he was mentored by the preeminent economist and author Phillip J Anderson. In 2015, he created The Newman Show Podcast, tapping into his network of contacts, including investing legend Jim Rogers, plus best-selling authors Jim Rickards, George Friedman, and Richard Maybury. He also launched Money Morning Trader, the popular service profiling the hottest stocks on the ASX each trading day.

Today, he helms the ultra-fast-paced stock trading service Small-Cap Systems and small-cap advisory Australian Small-Cap Investigator.

Callum’s Premium Subscriptions

Publication logo
James Altucher’s Investment Network Australia
Publication logo
Australian Small-Cap Investigator
Publication logo
Small-Cap Systems

Latest Articles

  • America on a War Footing: Implications as US Mineral Strategy Turns to Africa
    By James Cooper

    Geologist James Cooper examines the potential implications of America’s heavy focus on West Africa. Why is the US becoming deeply involved here? And what could the consequences be?

  • The biggest quarter on record for this share
    By Callum Newman

    We can see why the stock market didn’t react much to the RBA holding rates steady last meeting. Everyone expects rates to go down. It’s just a question of when. Fixed rate loans, and refinancings, are withering away as the market positions for more rate cuts. This is what you and I want to see as investors…

  • The US$2 Trillion Stablecoin Tsunami
    By Charlie Ormond

    These developments could transform the US$250 billion stablecoin market into a US$2 trillion juggernaut within years.

Primary Sidebar

Latest Articles

  • America on a War Footing: Implications as US Mineral Strategy Turns to Africa
  • The biggest quarter on record for this share
  • The US$2 Trillion Stablecoin Tsunami
  • Trump Sparks Rare Earth Rally
  • Copper Breaks Out: Are You Positioned?

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988